ArticleThe Kaohsiung journal of medical sciences2017

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.

Pei-Chien Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.